‌

US Patent 9770505 Vaccine composition with aluminium hydroxide nanoparticles

Patent 9770505 was granted and assigned to Sanofi Pasteur on September, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Sanofi Pasteur

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9770505

Patent Inventor Names

Jean Haensler0

Marie Garinot0

Joel Patarin0

Yannick Mathieu0

Valentin Valtchev0

Benedicte Lebeau0

Elisabeth Sauzeat0

Date of Patent

September 26, 2017

Patent Application Number

14131616

Date Filed

July 12, 2012

Patent Primary Examiner

‌

Agnieszka Boesen

Patent abstract

A vaccine composition comprising at least one antigen and one adjuvant, characterized in that the adjuvant comprises sterile-filterable nanoparticles comprising pseudo-boehmite and polyacrylate.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9770505 Vaccine composition with aluminium hydroxide nanoparticles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API